You’re benefiting from Extendicare’s focus

Article Excerpt

Extendicare sold off its retirement living operations in 2022, and its current focus on long-term care homes and home health care has paid off. The stock has now regained all the ground it lost after the onset of the pandemic—we think it can go higher. Extendicare is a Power Buy. EXTENDICARE INC., $9.37, is a buy. The company (Toronto symbol EXE; TSINetwork Rating: Extra Risk) (www.extendicare.com; Shares o/s: 83.5 million; Market cap: $782.1 million; Dividend yield: 5.1%) owns and operates long-term care homes. It also provides contract services to long-term care homes and retirement communities through Extendicare Assist. In all, it operates a network of 123 long-term care homes in Ontario, Manitoba and Alberta (52 owned with 7,113 beds; 71 under management contracts with 9,777 beds). Through its SGP Purchasing Partner Network. Extendicare provides group purchasing services to third parties representing 140,900 beds across Canada. Investors also tap the company’s ParaMed Home Health Care branches, mostly in Ontario and Alberta. ParaMed provides nursing care and other forms of…